| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |